Age-related macular degeneration is a bilateral ocular condition in which the central area of the retina, known as the macula, is affected.
This report aims to provide a comprehensive presentation of the global market for Age-Related Macular Degeneration (AMD) Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Age-Related Macular Degeneration (AMD) Therapeutics. This report contains market size and forecasts of Age-Related Macular Degeneration (AMD) Therapeutics in global, including the following market information:
Global Age-Related Macular Degeneration (AMD) Therapeutics Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
Report Sample includes: - Table of Contents - List of Tables & Figures - Charts - Research Methodology Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-agerelated-macular-degeneration-therapeutics-forecast-2023-2030-75
Age-related macular degeneration is a progressive condition, and it is common among the geriatric population. The growing geriatric population is contributing to the rising incidence of age-related macular degeneration globally. As a result, there is a high demand for therapeutics to treat the condition. Pharmaceutical companies are leveraging this opportunity and are focusing on releasing drugs to treat age-related macular degeneration.
We surveyed the Age-Related Macular Degeneration (AMD) Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Age-Related Macular Degeneration (AMD) Therapeutics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Age-Related Macular Degeneration (AMD) Therapeutics Market Segment Percentages, by Type, 2022 (%)
Wet AMD
Dry AMD
Global Age-Related Macular Degeneration (AMD) Therapeutics Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Research Institute
Other
Global Age-Related Macular Degeneration (AMD) Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Age-Related Macular Degeneration (AMD) Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Age-Related Macular Degeneration (AMD) Therapeutics revenues share in global market, 2022 (%)
Amgen Inc.
Bausch Health Companies, Inc.
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
Chapter 1: Introduces the definition of Age-Related Macular Degeneration (AMD) Therapeutics, market overview.
Chapter 2: Global Age-Related Macular Degeneration (AMD) Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Age-Related Macular Degeneration (AMD) Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Age-Related Macular Degeneration (AMD) Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
Get the Complete Report & TOC at https://www.24marketreports.com/life-sciences/global-agerelated-macular-degeneration-therapeutics-forecast-2023-2030-75
CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports
Comentarios